Multivitamins neither help nor hinder heart risk, finds study
Taking a multivitamin has no significant impact on your risk of experiencing a heart attack or other cardiovascular episode, a new study says.
Archives for April 6, 2017
Gnosis gets FDA no objection GRAS for non-animal chondroitin
The US Food and Drug Administration (FDA) has issued a letter of no objection for the GRAS (Generally Recognized as Safe) status of Gnosis S.p.A.’s Mythocondro-branded non-animal chondroitin sulfate for use in foods and beverages.
Evolutionary explanation? Research reveals how gut bacteria adapted to human breast milk
Researchers say they have uncovered a possible evolutionary route for the mutually beneficial relationship between gut microbes and humans.
Nestle seals joint venture to improve nutrition among Chinese stroke patients
Nestle Health Science and the Chinese Stroke Association have entered into a collaboration to help stroke patients swallow with less difficulty.
Polyphenol pills counter inflammation in women on hormonal contraceptives: RCT
Supplements containing a mixture of polyphenols may counter increases in pro-inflammatory markers in women of childbearing age using combined hormonal contraceptives, says a new study.
EU nutrient content calculation guidelines need bolstering
European calculation guidelines on nutrient content in foods need finessing through training and improved software, so they can be rolled out and accepted by stakeholders, says a new paper.
Marmite on the mind? Research suggests Marmite impacts brain functioning
High consumption of vitamin B12-rich Marmite spread could alter brain activity by increasing certain chemical messengers, says new research.
Milk Specialties Global taps further into clean label with calcium caseinate from US rBGH-free milk
Milk Specialties Global, a dairy protein manufacturer based in Minnesota, has launched a clean label calcium caseinate produced from US milk to better target the growing sports nutrition market.
IP builds for agmatine use in supplements
The US Patent and Trademark Office (USPTO) has granted Gilad&Gilad an additional patent for agmatine for use in dietary supplements, nutraceuticals, and foods.
Adverse events database not useful for drawing safety conclusions, expert says
The carte blanche release of adverse events data could give a skewed view of the safety of the dietary supplement industry, one expert says.